pharmaceutical

Showing 15 posts of 797 posts found.

astrazeneca_building_white

NICE rejects AstraZeneca’s breast cancer drug Faslodex

September 1, 2017
Medical Communications, Sales and Marketing AstraZeneca, Cancer, Faslodex, breast cancer, life sciences, pharma, pharmaceutical

NICE has announced its decision to not recommend AstraZeneca’s breast cancer drug Faslodex (fulvestrant) in women who have oestrogen-receptor-positive, locally …

NHS pumps £100m into GP recruitment as numbers plummet

September 1, 2017
Medical Communications GP, NHS, biotech, drugs, pharma, pharmaceutical

The NHS has been forced to offer £100 million to recruitment agencies in order to plug growing gaps in the …

genentechlr

FDA approves treatment to counter CAR-T side-effects

August 31, 2017
Medical Communications, Sales and Marketing Genentech, Roche, biotech, drugs, pharma, pharmaceutical

On the day that FDA announced the first CAR-T therapy would be given market authorisation, it also announced that a …

lilly2_web

Lilly gets second shot at application for ‘blockbuster’ arthritis drug

August 31, 2017
Sales and Marketing Eli Lilly, arthritis, baricitinib, biotech, drugs, pharma, pharmaceutical

Earlier this year, Eli Lilly was on the receiving end of one of the most surprising setbacks in recent times …

novartis_hq_day

CAR-T treatment is given ‘historic’ first approval by FDA

August 31, 2017
Research and Development, Sales and Marketing CAR-T, Kymriah, Novartis, biotech, drugs, pharma, pharmaceutical

Novartis has received approval for its CAR-T treatment of paediatric and young adults with a form of acute lymphoblastic leukaemia …

2000px-flag_of_south_korea

J&J offers $134,000 grant to find the best start-up in South Korea

August 31, 2017
Research and Development J&J. pharma, Johnson & Johnson, drugs, life sciences, medicine, pharmaceutical, south korea

Johnson & Johnson is doubling down its efforts to grow its business in East Asia by identifying and recruiting promising …

Abbott issues patch for vulnerable heart devices

August 31, 2017
Medical Communications, Sales and Marketing Abbot, St. Jude, biotech, drugs, pharma, pharmaceutical

A year on from the revelation that digital pacemakers were vulnerable to hackers, Abbott and the FDA has announced that …

governance_guenterpeter

EVP of Diabetes decamps from Sanofi to become Almirall CEO

August 30, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Almirall, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi’s Executive Vice President of Diabetes & Cardiocascular, Peter Guenter, has opted to end his 22-year-long stay at the company …

fda_building_web

FDA approves first treatment for the ‘silent killer’

August 30, 2017
Research and Development, Sales and Marketing Chagas disease, FDA, biotech, drugs, pharma, pharmaceutical

The FDA has announced that it has granted an accelerated approval for the use of benznidazole in children between the ages …

brexit_flag_0

UK’s post-Brexit strategy looks to life sciences industry

August 30, 2017
Medical Communications, Research and Development UK, biotech, brexit, drugs, life sciences, pharma, pharmaceutical

The UK Government had already announced, as part of its industrial plan, that the life sciences were regarded as a …

astrazeneca_logo_building

AstraZeneca unloads another drug for $400m

August 29, 2017
Research and Development, Sales and Marketing AstraZeneca, Takeda, biotech, drugs, pharma, pharmaceutical

AstraZeneca has had to do a serious re-think of its portfolio post-Mystic failure and it has made another move to …

adults-1853851_960_720

Thyroid disorders: An illness underestimated

August 29, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Dr Bogumila Urgatz, Medical Director, Department Global Medical Affairs & General Medicine and Endocrinology, Merck KGaA discusses thryoid problems and …

Novartis’ drug prevents heart attacks and cancer but faces major challenges

August 29, 2017
Manufacturing and Production, Research and Development Novartis, biotech, drugs, pharma, pharmaceutical

It would be expected that when a company releases data to show that its drug, previously only used in a …

merckincweb

MSD scores trial success in reducing cardiovascular risk

August 29, 2017
Manufacturing and Production, Research and Development MSD, heart attack, heart disease, life sciences, pharma, pharmaceutical

New data on MSD’s anacetrapib has revealed that the drug was able to reduce risk of the risk of major …

gilead-sciences

Gilead captures Kite in $11.9bn deal

August 29, 2017
Manufacturing and Production, Sales and Marketing Gilead, biotech, drugs, kite pharma, pharma, pharmaceutical

Gilead had long been expected to make a serious acquisition to boost flagging growth and it finally made a move …

The Gateway to Local Adoption Series

Latest content